Search

everythinglearnresearchcommunity

for

Search:↓

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Divalproex sodium significantly improved headaches in two-thirds of patients.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Drug misuse can cause serious eye infections and other severe side effects.

Some gonadal hormone drugs can block filovirus entry into cells.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

High-dose methotrexate can cause severe skin and nail issues.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Clofazimine successfully treated a man's ashy dermatosis, clearing his skin lesions.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Vorasidenib can cause unusual hair growth.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Higher doses of the medication valproate can cause hair loss, which may stop when the dose is lowered or the medication is stopped.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Levetiracetam may cause hair loss, which can potentially reverse with lower doses or stopping the drug.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.